SANTEN PHARMACEUTICAL CO.,LTD. (4536) Other
Market cap
¥685.5B
P/E ratio
17.1x
Santen Pharmaceutical develops and sells eye care medicines and medical devices worldwide, specializing in ophthalmology products for both prescription and over-the-counter markets.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | 16.2 | 6.8 | 9.9 | 8.2 | 5.9 | 1.7 | 6.3 | 0.3 | 6.2 | 8.6 | 9 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 3,053 | 3,050 | 3,072 | 3,230 | 3,463 | 3,667 | 3,805 | 4,073 | 4,108 | 4,229 | 4,315 | 4,144 | 3,744 | 3,849 | 3,968 |
| Total payout ratio | - | - | - | - | - | - | 30 | 77.3 | 44 | - | 44.1 | -258.3 | 108.3 | 137.9 | 121.6 |